Literature DB >> 2098098

Defective response of natural killer activity to thyroxine in Graves' disease.

M S Lee1, W S Hong, S W Hong, J O Lee, T W Kang.   

Abstract

The effect of thyroxine (T4) on natural killer (NK) activity of peripheral blood lymphocytes (PBL) was investigated, using a 4-hr 51Cr release assay, in 18 patients with previously untreated Graves' disease and in 18 controls. NK activity in patients with Graves disease was not significantly different from that in the controls. Normal T4 (NT) and high T4 (HT) medium, free T4 concentrations in which were 1.01 and 16.3 ng/dl, respectively, were used to evaluate the effect of T4 on NK activity. In the controls, NK activity increased in the NT or HT medium compared with that in the control medium at effector to target cell (E:T) ratios of 25 : 1 and 50 : 1. NK activity in the Graves' disease patients, however, did not increase when either the NT or HT medium was used at E : T ratios of 25 : 1 and 50 : 1. These results suggest that patients with Graves' disease have a similar NK activity to the controls but have a defect in the peripheral blood lymphocytes to increase NK activity in response to T4.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2098098      PMCID: PMC4535009          DOI: 10.3904/kjim.1990.5.2.93

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  14 in total

1.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

2.  Natural killer and lymphokine-activated killer activities in stomach cancer patients with special emphasis on the effect of 5-fluorouracil, adriamycin and mitomycin-C chemotherapy.

Authors:  W S Hong; C M Kim; J O Lee; T W Kang; T K Yun; C Y Kim
Journal:  Jpn J Clin Oncol       Date:  1990-03       Impact factor: 3.019

Review 3.  Mechanisms of pancreatic beta-cell destruction in type I diabetes.

Authors:  J Nerup; T Mandrup-Poulsen; J Mølvig; S Helqvist; L Wogensen; J Egeberg
Journal:  Diabetes Care       Date:  1988 Nov-Dec       Impact factor: 19.112

4.  Suppression of natural cytotoxicity by spleen cells of hydrocortisone-treated mice.

Authors:  P S Hochman; G Cudkowicz
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

Review 5.  Human natural killer cells: biologic and pathologic aspects.

Authors:  G Trinchieri; B Perussia
Journal:  Lab Invest       Date:  1984-05       Impact factor: 5.662

Review 6.  Heterogeneity of natural killer cells.

Authors:  J R Ortaldo; R B Herberman
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

7.  Natural killer (NK) and lymphokine-activated killer (LAK) cell activity in healthy volunteers with special emphasis on the familial incidence of cancer.

Authors:  J Fujita; N Saijo; Y Sasaki; M Sakurai; T Sano; J Ishihara; H Takahashi; A Hoshi
Journal:  Jpn J Clin Oncol       Date:  1985-12       Impact factor: 3.019

8.  Enhancement of mouse natural killer cell activity by thyroxine.

Authors:  S D Sharma; V Tsai; M R Proffitt
Journal:  Cell Immunol       Date:  1982-10       Impact factor: 4.868

9.  Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells.

Authors:  P MacKay; J Jacobson; A Rabinovitch
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

10.  Thyroxine-dependent modulation of natural killer activity.

Authors:  M Provinciali; M Muzzioli; N Fabris
Journal:  J Exp Pathol       Date:  1987
View more
  1 in total

Review 1.  Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher.

Authors:  Daniela Gallo; Eliana Piantanida; Matteo Gallazzi; Luigi Bartalena; Maria Laura Tanda; Antonino Bruno; Lorenzo Mortara
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-17       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.